Form D · Other Health Care
INSONO THERAPEUTICS, INC.
Palo Alto, CA · CIK 0001554932
Offering snapshot reported Jul 25, 2012 · SEC filing
- Reported sold
- $210K Offering amount: $210K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 25, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2012 | Initial | $210,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181764
No commissions paid
Source: Form D, filed Jul 25, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anant Hegde | Director, Executive |
| Kasey Li | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2465 East Bayshore Road Suite 402
Palo Alto, CA, 94303
Palo Alto, CA, 94303